Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

The new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or ...

LA CAB plus RPV effectively maintained virologic suppression among patients with infection in real-world clinical practice.

The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of combination antiretroviral therapy ...

FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...